Edwards Lifesciences Corporation Operating Lease, Payments
Edwards Lifesciences Corporation (EW) reported Operating Lease, Payments of $15.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-08-04
- Edwards Lifesciences Corporation operating lease, payments for the quarter ending 2026-06-30 was $7.70M, a 2.67% increase year-over-year.
- Edwards Lifesciences Corporation operating lease, payments for the quarter ending 2026-03-31 was $7.30M, a 4.29% increase year-over-year.
- Edwards Lifesciences Corporation operating lease, payments for the quarter ending 2025-12-31 was $7.40M, a 5.71% increase year-over-year.
- Edwards Lifesciences Corporation operating lease, payments for the quarter ending 2025-09-30 was $7.40M, a 13.85% increase year-over-year.
- Edwards Lifesciences Corporation operating lease, payments for fiscal 2025 was $29.30M, a 4.64% increase from fiscal 2024.
- Edwards Lifesciences Corporation operating lease, payments for fiscal 2024 was $28.00M, a 8.95% increase from fiscal 2023.
- Edwards Lifesciences Corporation operating lease, payments for fiscal 2023 was $25.70M, a 2.80% increase from fiscal 2022.
- Edwards Lifesciences Corporation operating lease, payments for fiscal 2022 was $25.00M, a 21.63% decline from fiscal 2021.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 3 month as first filed | Operating Lease, Payments 6 month | Operating Lease, Payments 6 month as first filed | Operating Lease, Payments 9 month | Operating Lease, Payments 9 month as first filed | Operating Lease, Payments 12 month | Operating Lease, Payments 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $7.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $15.00M 10-Q · filed 2026-08-04 | $22.40M derived: sum of 3 quarters · filed 2026-08-04 | $29.80M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | $7.30M 10-Q · filed 2026-05-06 | $14.70M derived: sum of 2 quarters · filed 2026-05-06 | $22.10M derived: sum of 3 quarters · filed 2026-05-06 | $29.60M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | $7.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $14.80M derived: sum of 2 quarters · filed 2026-02-25 | $22.30M derived: sum of 3 quarters · filed 2026-08-04 | $29.30M 10-K · filed 2026-02-25 | ||||
| 2025-09-30 | $7.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $14.90M derived: sum of 2 quarters · filed 2026-08-04 | $21.90M 10-Q · filed 2025-11-05 | $28.90M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | $7.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $14.50M 10-Q · filed 2026-08-04 | $21.50M derived: sum of 3 quarters · filed 2026-08-04 | $28.00M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | $7.00M 10-Q · filed 2026-05-06 | $14.00M derived: sum of 2 quarters · filed 2026-05-06 | $20.50M derived: sum of 3 quarters · filed 2026-05-06 | $27.70M derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | $7.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $13.50M derived: sum of 2 quarters · filed 2026-02-25 | $20.70M derived: sum of 3 quarters · filed 2026-02-25 | $28.00M 10-K · filed 2026-02-25 | ||||
| 2024-09-30 | $6.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $13.70M derived: sum of 2 quarters · filed 2025-11-05 | $21.00M 10-Q · filed 2025-11-05 | $27.60M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-06-30 | $7.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $14.50M 10-Q · filed 2025-08-06 | $21.10M derived: sum of 3 quarters · filed 2026-02-25 | $27.50M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-03-31 | $7.30M 10-Q · filed 2025-05-06 | $8.20M 10-Q · filed 2024-04-29 | $13.90M derived: sum of 2 quarters · filed 2026-02-25 | $20.30M derived: sum of 3 quarters · filed 2026-02-25 | $25.90M derived: sum of 4 quarters · filed 2026-02-25 | |||
| 2023-12-31 | $6.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $13.00M derived: sum of 2 quarters · filed 2026-02-25 | $18.60M derived: sum of 3 quarters · filed 2026-02-25 | $25.70M 10-K · filed 2026-02-25 | $28.80M 10-K · filed 2024-02-12 | |||
| 2023-09-30 | $6.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $12.00M derived: sum of 2 quarters · filed 2024-11-06 | $19.10M 10-Q · filed 2024-11-06 | $21.50M 10-Q · filed 2023-10-27 | $21.90M derived: sum of 4 quarters · filed 2025-02-28 | |||
| 2023-06-30 | $5.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $12.70M 10-Q · filed 2024-07-31 | $14.30M 10-Q · filed 2023-07-28 | $15.50M derived: sum of 3 quarters · filed 2025-02-28 | $23.20M derived: sum of 4 quarters · filed 2025-02-28 | |||
| 2023-03-31 | $7.10M 10-Q · filed 2024-04-29 | $9.90M derived: sum of 2 quarters · filed 2025-02-28 | $17.60M derived: sum of 3 quarters · filed 2025-02-28 | $24.50M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2022-12-31 | $2.80M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $10.50M derived: sum of 2 quarters · filed 2025-02-28 | $17.40M derived: sum of 3 quarters · filed 2025-02-28 | $25.00M 10-K · filed 2025-02-28 | $28.10M 10-K · filed 2023-02-13 | |||
| 2022-09-30 | $7.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-27 | $14.60M derived: sum of 2 quarters · filed 2023-10-27 | $22.20M 10-Q · filed 2023-10-27 | $30.00M derived: sum of 4 quarters · filed 2024-02-12 | ||||
| 2022-06-30 | $6.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-28 | $14.50M 10-Q · filed 2023-07-28 | $22.30M derived: sum of 3 quarters · filed 2024-02-12 | $30.10M derived: sum of 4 quarters · filed 2024-02-12 | ||||
| 2022-03-31 | $7.60M 10-Q · filed 2023-04-28 | $15.40M derived: sum of 2 quarters · filed 2024-02-12 | $23.20M derived: sum of 3 quarters · filed 2024-02-12 | $31.80M derived: sum of 4 quarters · filed 2024-02-12 | ||||
| 2021-12-31 | $7.80M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-12 | $15.60M derived: sum of 2 quarters · filed 2024-02-12 | $24.20M derived: sum of 3 quarters · filed 2024-02-12 | $31.90M 10-K · filed 2024-02-12 | ||||
| 2021-09-30 | $7.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28 | $16.40M derived: sum of 2 quarters · filed 2022-10-28 | $24.10M 10-Q · filed 2022-10-28 | $32.10M derived: sum of 4 quarters · filed 2023-02-13 | ||||
| 2021-06-30 | $8.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-29 | $16.30M 10-Q · filed 2022-07-29 | $24.30M derived: sum of 3 quarters · filed 2023-02-13 | $31.90M derived: sum of 4 quarters · filed 2023-02-13 | ||||
| 2021-03-31 | $7.70M 10-Q · filed 2022-04-28 | $15.70M derived: sum of 2 quarters · filed 2023-02-13 | $23.30M derived: sum of 3 quarters · filed 2023-02-13 | $30.30M derived: sum of 4 quarters · filed 2023-02-13 | ||||
| 2020-12-31 | $8.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-13 | $15.60M derived: sum of 2 quarters · filed 2023-02-13 | $22.60M derived: sum of 3 quarters · filed 2023-02-13 | $29.70M 10-K · filed 2023-02-13 | ||||
| 2020-09-30 | $7.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-29 | $14.60M derived: sum of 2 quarters · filed 2021-10-29 | $21.70M 10-Q · filed 2021-10-29 | $30.80M derived: sum of 4 quarters · filed 2022-02-14 | ||||
| 2020-06-30 | $7.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | $14.10M 10-Q · filed 2021-07-30 | $23.20M derived: sum of 3 quarters · filed 2022-02-14 | $30.00M derived: sum of 4 quarters · filed 2022-02-14 | ||||
| 2020-03-31 | $7.10M 10-Q · filed 2021-04-28 | $16.20M derived: sum of 2 quarters · filed 2022-02-14 | $23.00M derived: sum of 3 quarters · filed 2022-02-14 | $29.60M derived: sum of 4 quarters · filed 2022-02-14 | ||||
| 2019-12-31 | $9.10M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-14 | $15.90M derived: sum of 2 quarters · filed 2022-02-14 | $22.50M derived: sum of 3 quarters · filed 2022-02-14 | $28.60M 10-K · filed 2022-02-14 | ||||
| 2019-09-30 | $6.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-26 | $13.40M derived: sum of 2 quarters · filed 2020-10-26 | $19.50M 10-Q · filed 2020-10-26 | $19.50M derived: sum of 4 quarters · filed 2021-02-12 | ||||
| 2019-06-30 | $6.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-27 | $12.70M 10-Q · filed 2020-07-27 | $12.70M derived: sum of 3 quarters · filed 2021-02-12 | $12.70M derived: sum of 4 quarters · filed 2021-02-12 | ||||
| 2019-03-31 | $6.10M 10-Q · filed 2020-04-28 | $6.10M derived: sum of 2 quarters · filed 2021-02-12 | $6.10M derived: sum of 3 quarters · filed 2021-02-12 | $6.10M derived: sum of 4 quarters · filed 2021-02-12 | ||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | $0.00 derived: sum of 2 quarters · filed 2021-02-12 | $0.00 derived: sum of 3 quarters · filed 2021-02-12 | $0.00 10-K · filed 2021-02-12 | ||||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-25 | $0.00 derived: sum of 2 quarters · filed 2019-10-25 | $0.00 10-Q · filed 2019-10-25 | |||||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-26 | $0.00 10-Q · filed 2019-07-26 | ||||||
| 2018-03-31 | $0.00 10-Q · filed 2019-04-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |